Women's Health MRI

Catch up on the top AI-related news and research in radiology over the past month.

The update of the S-scan magnetic resonance imaging (MRI) system reportedly offers an improved ergonomic design, algorithms to enhance image quality and reduced scan times.

A 49-study meta-analysis revealed that MRI-based and CT-based radiomics models outperformed clinical models for predicting recurrence of hepatocellular carcinoma.

The artificial intelligence (AI)-powered software VUNO Med-DeepBrain reportedly automates brain MRI segmentation and provides access to volumetric data on over 100 regions of the brain.

Catch up on the top radiology content of the past week.

In a newly published literature review, researchers examined the benefits of diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) for breast cancer characterization and monitoring of neoadjuvant chemotherapy, current drawbacks that thwart wider adoption, and emerging techniques that may enhance the modality’s effectiveness.

Review the case study and test your knowledge to make the correct diagnosis.

In reportedly the eighth FDA 510(k) clearance for Hyperfine’s Swoop portable brain MRI device, clinicians will now have access to enhanced denoising capabilities with diffusion-weighted imaging (DWI) sequences.

Catch up on the top radiology news of the past week.

Researchers found that the combination of a retrovesicourethral angle, functional urethral length, and bladder funnel on MRI exams in primiparous women had a 94.7 percent AUC for predicting postpartum stress urinary incontinence (SUI).

The MAGNETOM Viato.Mobile may facilitate improved access to MRI capabilities for patients with serious health conditions who lack geographic proximity to centers with advanced imaging.

For patients discharged from the hospital with confirmed COVID-19, median five-month follow-up MRI findings revealed a greater likelihood of regional brain volume reduction, parenchymal lung abnormalities and loss of corticomedullary differentiation in the kidney in comparison to people who have not had COVID-19.

Catch up on the top AI-related news and research in radiology over the past month.

New research suggests the capability of a mammography-based deep learning model to identify women at high risk of breast cancer led to more than triple the cancer detection rate on breast MRI in comparison to traditional risk assessment tools.

The artificial intelligence (AI)-enabled AIRAscore can reportedly provide quantitative brain volume data within five minutes of assessing brain MRI scans.

Catch up on the top radiology content of the past week.

A robotic guidance and placement system, the IGAR system can be utilized inside of a magnetic resonance imaging (MRI) bore.

Catch up on the top radiology content of the past week.

Through the use of artificial intelligence (AI) and imaging modalities such as ultrasound, CT, and MRI, the newly FDA-cleared VisAble.IO software reportedly enhances planning and real-time assessment for liver tumor ablation procedures.

Catch up on the top radiology content of the past week.

Catch up on the top five most viewed content at Diagnostic Imaging in August 2023.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

The Echelon Synergy MRI system reportedly uses deep learning technology to accelerate image acquisition and enhance image quality.

Catch up on the top radiology content of the past week.

In a new study comparing standard breast MRI, abbreviated breast MRI and contrast-enhanced mammography in supplemental breast cancer screening, researchers found that MRI offered a greater than 14 percent higher cancer detection rate and a nearly 39 percent higher sensitivity rate than CEM.

Catch up on the top radiology content of the past week.

Emerging research suggests that a high volume of enhancing parenchyma on dynamic contrast-enhanced MRI more than doubles the breast cancer risk for women with extremely dense breasts.

The most common brain MRI findings associated with COVID-19 included acute/subacute infarction in 22 percent of patients and cerebral microbleeds in 17 percent of patients.

The indications for Gadobutrol injection, a generic substitute for Gadavist, include neurovascular and cardiovascular assessments as well as breast malignancy detection with magnetic resonance imaging (MRI).